LivaNova PLC
LIVN
Clasificación en acciones
#3821
LivaNova PLC is a global medical technology company dedicated to developing,... LivaNova PLC is a global medical technology company dedicated to developing, manufacturing, and marketing a variety of therapeutic solutions. The company operates through three key segments. Its Cardiopulmonary division provides essential products for heart-lung procedures, such as oxygenators, heart-lung machines, and various perfusion systems. The Neuromodulation segment is known for its VNS Therapy System, an implantable device that delivers vagus nerve stimulation to treat drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. This segment is also advancing the VITARIA System, which employs VNS for heart failure, through clinical development. The Advanced Circulatory Support segment offers temporary life support solutions, including both cardiopulmonary and respiratory support technologies. LivaNova serves a wide range of medical professionals, including perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals and healthcare providers. The company's products are distributed globally through both its direct sales force and independent distributors. Additionally, LivaNova has a research collaboration with Verily aimed at discovering clinical biomarkers for depression. Founded in 1987, the company is headquartered in London, United Kingdom.
Precio por acción
$78.25
Última sincronización: 2026-10-21
Capitalización bursátil
$4.30B
Cambio (1 día)
-1.84%
Cambio (1 año)
42.65%
País
GB
Comercio LivaNova PLC (LIVN)
Categoría
Healthcare
Ingresos de LivaNova PLC (LIVN)
Ingresos en Jun 2026 TTM: $1.47B
Según los últimos informes financieros de LivaNova PLC, los ingresos actuales de la empresa (TTM) son $1.47B. En 2023, la empresa obtuvo unos ingresos de $1.15B un aumento con respecto a los ingresos del año 2022, que fueron de $1.02B. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de LivaNova PLC desde 2000 hasta 2026
Ingresos al final de cada año
| Año | Ingresos | Cambiar |
|---|---|---|
| 2026 (TTM) | $1.47B | 17.40% |
| 2024 | $1.25B | 8.66% |
| 2023 | $1.15B | 12.89% |
| 2022 | $1.02B | -1.31% |
| 2021 | $1.04B | 10.82% |
| 2020 | $934.24M | -13.83% |
| 2019 | $1.08B | -2.06% |
| 2018 | $1.11B | 9.35% |
| 2017 | $1.01B | -16.61% |
| 2016 | $1.21B | 316.35% |
| 2015 | $291.56M | 3.38% |
| 2014 | $282.01M | 10.89% |
| 2013 | $254.32M | 16.39% |
| 2012 | $218.50M | 14.72% |
| 2011 | $190.46M | 13.52% |
| 2010 | $167.78M | 16.83% |
| 2009 | $143.60M | 18.45% |
| 2008 | $121.23M | -7.44% |
| 2007 | $130.97M | 6.10% |
| 2006 | $123.44M | 19.33% |
| 2005 | $103.44M | -6.57% |
| 2004 | $110.72M | 5.99% |
| 2003 | $104.47M | 49.00% |
| 2002 | $70.11M | 46.40% |
| 2000 | $47.89M | 0.00% |
Ingresos de empresas similares o competidoras
| Empresa | Ingresos | Diferencia de ingresos | País |
|---|---|---|---|
| $46.59B | 3,065.79% |
US
|
|
| $35.48B | 2,311.40% |
IE
|
|
| $25.84B | 1,655.81% |
US
|
|
| $21.00B | 1,326.83% |
US
|
|
| - | - |
DE
|
